Better Adherence: Easing the sting makes it easier to stick to your injection schedule, which is crucial for seeing steady weight loss progress
P-rank scores show that SGLT-2 inhibitors were ranked first in reducing CV death (84.8%) (Additional file 1: Table S2)
Gastrointestinal symptoms during dose changes Nausea, constipation, and other GI symptoms are the most common side effects of GLP-1 therapy, and they tend to re-emerge whenever dosing changes occur
It offers robust weight-loss outcomes, but its effect on energy expenditure is less pronounced compared to glucagon-targeting therapies
Prescriptions for semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have grown steadily, and so has the number of people asking one practical question: can I keep taking my probiotic
Weight loss is an important journey